Literature DB >> 2989181

Enhanced superoxide release and tumoricidal activity by a postlavage, in situ pulmonary macrophage population in response to activation by Mycobacterium bovis BCG exposure.

D B Drath.   

Abstract

The monocytic phagocyte population of rat lungs is heterogeneous. In addition to the freely lavagable alveolar macrophages, there is a fixed in situ tissue-associated subpopulation of pulmonary macrophages. The response of this subpopulation to classical macrophage activation by Mycobacterium bovis BCG exposure was monitored. Results indicate that this population can be activated both metabolically and functionally, as evidenced by enhanced release of superoxide anions and demonstrable tumoricidal activity against syngeneic and xenogeneic target cells. The pattern of metabolic activation of in situ tissue-associated macrophages differed somewhat from that of alveolar macrophages and was observed only after subsequent exposure of the cells to either zymosan particles or phorbol myristate acetate. Upon such exposure, the activated zymosan-treated tissue macrophages released approximately twice as much superoxide as the nonactivated cells and amounts comparable to the amounts released by activated alveolar macrophages. The tissue macrophages also displayed greater levels of cytotoxicity toward xenogenic targets than the alveolar cells and may have an important role in preventing microbial or tumor cell colonization of respiratory systems.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989181      PMCID: PMC262060          DOI: 10.1128/iai.49.1.72-75.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  The use of freshly explanted mouse epidermal cells for the in vitro induction and detection of cell-mediated cytotoxicity.

Authors:  D Steinmuller; J R Wunderlich
Journal:  Cell Immunol       Date:  1976-06-01       Impact factor: 4.868

2.  Inhibition of pulmonary metastasis by intravenous injection of specifically activated macrophages.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1974-05       Impact factor: 12.701

3.  Peroxidatic activity and morphometric analysis of alveolar macrophages in the guinea pig.

Authors:  M R Soranzo; H K Koerten; W T Daems
Journal:  J Reticuloendothel Soc       Date:  1978-05

4.  Heterogeneity of rat peritoneal and alveolar macrophage populations: spontaneous rosette formation using sheep and chicken red blood cells.

Authors:  M A Thomas; I Galbraith; R N MacSween
Journal:  J Reticuloendothel Soc       Date:  1978-01

5.  Tumor cytotoxicity of rat alveolar macrophages activated in vitro by endotoxin.

Authors:  S Sone; I J Fidler
Journal:  J Reticuloendothel Soc       Date:  1980-03

6.  The organ distribution of disseminated 51 Cr-labeled tumor cells.

Authors:  B Fisher; E R Fisher
Journal:  Cancer Res       Date:  1967-02       Impact factor: 12.701

7.  Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.

Authors:  I J Fidler; Z Barnes; W E Fogler; R Kirsh; P Bugelski; G Poste
Journal:  Cancer Res       Date:  1982-02       Impact factor: 12.701

8.  Origin, Kinetics, and characteristics of pulmonary macrophages in the normal steady state.

Authors:  A B van oud Alblas; R van Furth
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307

9.  Cellular resistance to infection.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1962-09-01       Impact factor: 14.307

10.  Superoxide production by phagocytic leukocytes.

Authors:  D B Drath; M L Karnovsky
Journal:  J Exp Med       Date:  1975-01-01       Impact factor: 14.307

View more
  2 in total

1.  Activation of rat alveolar macrophages and protection against i.v. injected tumor cells by intratracheal administration of trehalose dimycolate.

Authors:  D Nolibe; R Masse; J P Tenu; M Lepoivre; J F Petit
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Interactions between human monocytes and tumour cells. Monocytes can either enhance or inhibit the growth and survival of K562 cells.

Authors:  B Davies; S W Edwards
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.